RayzeBio, Inc. — Form D
RayzeBio, Inc. of SAN DIEGO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2022-09-22. The offering totals $167.9M, of which $167.9M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-09-22
- Form: D
- Accession: 0001916991-22-000003
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $167.9M
- Amount sold: $167.9M
- Investors: 18
- Date of first sale: 2022-08-25
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-459654
Issuer
- Name: RayzeBio, Inc.
- CIK: 0001825367
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2020
- Address: 5505 MOREHOUSE DRIVE, SUITE 300, SAN DIEGO, CA, 92121
- Phone: (619) 937-2754
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Jerel Davis | Director | Alameda, CA |
| Aaron Kantoff | Director | Rockville, MD |
| Maha Katabi | Director | San Francisco, CA |
| Yi Larson | Director | San Diego, CA |
| Alex Rosen | Director | New York, NY |
| Aaron Royston | Director | Cambridge, MA |
| Ken Song | Director | San Diego, CA |
| Mary Tagliaferri | Director | San Diego, CA |
| Angie You | Director | San Diego, CA |
| Aubrey Haddach | Executive Officer | San Diego, CA |
| Arvind Kush | Executive Officer | San Diego, CA |
| Ken Song | Executive Officer | San Diego, CA |
| Bong Koh | Director | Willow Grove, PA |
| Deborah Charych | Executive Officer | San Diego, CA |
Other filings by this issuer (3)
More